Tag: Globally

chep-accredited-as-a-top-employer-in-india

CHEP accredited as a Top Employer in India

January 27, 2023 Published by

 

CHEP, a global leader in supply chain solutions, has been certified as a Top Employer in India for 2023 by Top Employers Institute, a global certifier recognising excellence in employee conditions.

This year, CHEP, as part of the Brambles Group, was among only 15 organisations to receive the Global Top Employer certification, which is awarded to companies demonstrating outstanding HR policies and practices worldwide.

Human Resources Vice President for CHEP Asia Pacific, India, Middle East, Tὓrkiye and Africa, Victoria Pickles, says, “We are immensely proud to have achieved global recognition for the first time from Top Employer. We create a working environment that supports our employees and rewards excellence, honesty, mutual respect, and fairness. We thank all our employees for their significant efforts and engagement in building CHEP into the organisation it is today. It is through the collective efforts of our teams working every day towards creating the best possible employee experience for our people that has made this possible. The certification recognises the ongoing efforts we are applying to building a safe, inclusive and respectful workplace that offers employees a purposeful and fulfilling experience. Our people first policies are creating an environment where innovation, diversity and growth are encouraged and we are proud to be on this journey together.”

Megeshni Archary, Vice President for CHEP India, Middle East and North Africa recognises that its people are its most valuable asset. “At CHEP, we have achieved high employee engagement by aligning our organisation’s purpose with those of our people. We understand that employee engagement is key to delivering effectively for our customers and all our stakeholders,” says Mrs. Archary. “With our sustainable share-and-reuse business model, our development initiatives, and our diversity-and-inclusion programmes, we believe we are building a company that our employees are proud to be part of. We continuously strive to be the best company to work for across all our offices around the world.”

The Top Employers Institute programme certifies organisations based on the participation and results of their HR Best Practices Survey. This survey covers six HR domains consisting of 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Diversity & Inclusion, Wellbeing and more.

In 2022, CHEP achieved 33% of women in management roles globally and reached 40% female representation on its Board. Following an increased focus employee health, safety and wellbeing, the company recorded an 18% improvement in its Brambles Injury Frequency Rate (BIFR) performance, reflecting the targeted efforts to reach Zero Harm across global operations with the rollout of its Safety-First roadmap.

Top Employers Institute CEO, David Plink, said, “Exceptional times bring out the best in people and organisations. And we have witnessed this in our Top Employers Certification Programme this year: an exceptional performance from the certified Top Employers 2023. Amongst this community of outstanding organisations, CHEP has proven its commitment to employees on a global scale. This consistency in people practices across the globe characterises an exclusive group of companies that have achieved a global certification through the Top Employers Programme. We are proud to announce and celebrate these companies and their achievement in 2023.”

Globally, CHEP has been recognised as a Top Employer in 25 countries including Australia, Argentina, Belgium, Brazil, Canada, Chile, Czech Republic, France, Germany, India, Ireland, Italy, Malaysia, Mexico, Namibia, New Zealand, Poland, Saudi Arabia, South Africa, Spain, Swaziland, Thailand, Zimbabwe, United Kingdom and United States, while also earning the regional Top Employer seal in Africa, Asia Pacific, Europe and Latin America.

at-84%-cagr,-probiotics-market-size-is-expected-to-reach-usd-108.16-billion-to-2028-by-globally,-says-brandessence-market-research

At 8.4% CAGR, Probiotics Market Size is Expected to Reach USD 108.16 Billion to 2028 By Globally, says Brandessence Market Research

March 8, 2022 Published by

 

The Probiotics Market size reached USD 61.50 Billion in 2021. The Probiotics Market is growing at robust CAGR of 8.4%, and reach size of USD 108.16 Billion by end of Forecast 2028 Research Report Published by Brandessence Market Research.

Increasing demand of dietary supplements coupled with a preference towards healthy foods probiotics for immunity boosting, rising geriatric population and growing awareness regarding the health benefits of consuming probiotics amongst consumers are some of the major factors anticipated to drive the growth of Global Probiotic Market.

An unforeseen illness in the world that is the COVID-19 has plagued the world in the last few years and that has affected the market in a positive way as there has been a growth in awareness of the probiotic product. The upsurge in the health concerns as well as the consumer awareness and the demands of the consumers for the probiotics which has been resulting in the increase of the food products and probiotics diary. Further, the available stock in medical health department have been giving consumers a lot of options such as the ice cream, yoghurt and cheese for the consumption of the beneficial bacteria.

Get Sample of Report@ https://brandessenceresearch.com/requestSample/PostId/1893

Scope of The Probiotics Market Report:

The global probiotics market has been the one that is expected to see a good amount of growth in the next decade or so. Probiotics are the microorganisms like yeast and bacteria which has helped the animals and humans maintain the balance of intestinal microbial balance. The ingredients of probiotics stimulate the natural enzymes and digestive juices in the body and ensure that the proper functions of digestion are taking place. These may be taken as supplements or orally. Probiotic shields are the healthy organisms which prevent the harmful ones. The products are used for diagnosing mental illness as well as treating the neurological disorders and digestive issues. Also, these strengthen the immune system of humans, protect the proteins and lipids from damages and reduce the body pathogens.

There is an increase in the preferences of the consumers towards the natural products and that has to act as a big factor that will play in the favor of the global market growth. The growing concern that the consumers have towards the healthcare and the effectiveness of this bacteria which has been proven are expanding the global market. The probiotics demand has been expected to see an increase because of an exponential growth in functional food consumption which further provides the basic nutrition and can potentially improve the health.

The Probiotics  major companies

  • Nestle S.A.
  • Yakult Honsha Co. Ltd.
  • Protexin
  • Danone
  • Chr. Yakult Honsha Co. Ltd.
  • Probi AB, Inc.
  • Nestle S.A.
  • Hansen Holding A/S
  • E. I. du Pont de Nemours and Company
  • Bio Gaia AB
  • Lifeway Foods
  • Ganeden, Inc.

Purchase This Report at Special Price @ https://brandessenceresearch.com/Checkout?report_id=1893

Segmentation Analysis:

As per the segmentation of the probiotics market analysis, this market has been segmented into the application, function, ingredient, region and end user. In terms of ingredient the global market has been categorized into yeast and bacteria. On the basis of functionality, this market has been segmented into preventive, therapeutic and regular healthcare. In terms of application, this market has been segmented into dietary supplement, food and beverage as well as animal feed. In terms of end users, it has been segmented into the animal and human segment.

In terms of ingredient, bacteria segment has been gaining the biggest share in the market because of the surging demand for the probiotics which are bacteria derived. On the basis of function, the segment of the preventive healthcare has been leading the market which the biggest share in the coming years. This has been due to the growing issues in health and the marketing investments in research and development. On the basis of application, it is the dietary supplements which has been the segment that has been acquiring the top position and the biggest share in the market. This is also because a few manufacturers have been adding different forms of dietary fibers along with other products. In terms of the end users, the human segment has been doing well as there is a drive to keep the gut healthy that has grown the demand in the market. In terms of region, the probiotics market size has grown in the Asia pacific region and there is going to be further growth in the market as the population becomes more conscious.

By Application:

  • Food & Beverages
  • Dietary Supplements
  • Animal Feed

By Function:

  • Regular
  • Preventative Healthcare
  • Therapeutic

By Ingredient:

  • Bacteria
  • Yeast

By End-Use:

  • Human Probiotics
  • Animal Probiotics

Key Benefits:

A lot of people in the world today are suffering from digestive issues, obesity, vaginal infections, gastrointestinal infections as well as other ailments. Taking these things in contention, the global market has been expected to grow as the demand for the treatment of these illnesses comes in probiotics market. There is also a great increase in the health concerns of people and it is only going to grow in the coming years. Probiotics ingredients market will also consequently grow.

A lot of the consumers who are not aware of the benefits of the probiotics are restraining the global market. There are many publications which the organizations are trying to come out with to raise the awareness levels of people towards the probiotic consumption. This has been coupled with the research and development that has been done by the companies to meet the needs of the industry and be competitive in the global market. There is huge investment which can be expected in future for the improvement of quality of these products. Probiotic market size will grow as a result in the near future.

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1893

Recent Development:

Indian Scientists Developed Next-Generation Probiotic That Provides Hope for Longevity, Healthy Ageing

On February 11th, 2022; A team of scientists at the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science & Technology, Govt. of India recognized the next-generation probiotic bacterium Lactobacillus Plantarum JBC5 from a dairy food product that showed great promise in promoting healthy ageing. The team has also developed a yogurt using this probiotic bacterium which may be consumed to derive of these health benefits. The recent advances in life science have increased anticipation and have led to the rapid climb of the aging population. The scientists found the next-generation probiotic bacterium Lactobacillus Plantarum JBC5 from a foodstuff that shows great promise in promoting healthy aging on a model organism called Caenorhabditis Elegans a free-living, transparent nematode living temperate soil environments.

Probiotics Market Demand:

The global probiotics market growth can be directly said to be proportional to the increase in favorable support by governments and increase in consumer spending; that is a big factor which has been driving the growth of this market. The surge in this demand for the product among the conscious consumers is driving the growth of the probiotics market.

There is a dearth of proper regulations in this industry and that has been expected to impede the growth of the market. Further, the probiotics have a need for storing it properly as they are organisms which can be weakened easily as they are highly sensitive to many external factors. Further, a lot of these probiotics are not stable at the room temperature and these are factors which cause hindrance to the growth of the global market.

The geriatric population and the constant awareness strategies of companies to make people aware of the probiotic health benefits has been expected to drive the growth and opportunities significantly. There is a further rise in the working women population and increase in the spend of the food products has been touted to grow the overall probiotics market share.

On Special Requirement Probiotics Market Report is also available for below region:

North America

  • U.S, Canada

Europe

  • Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

  • South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Get Full Access of all Report: https://brandessenceresearch.com/food-and-beverage/probiotic-market-size

Reports:

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic.  Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

organoids-market-size-worth-$3,42040-million,-globally,-by-2027-at-22.1%-cagr-–-exclusive-report-by-the-insight-partners

Organoids Market Size Worth $3,420.40 Million, Globally, by 2027 at 22.1% CAGR – Exclusive Report by The Insight Partners

January 20, 2022 Published by

 

According to the new market research report “Organoids Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, Others); Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, Others); Source (Pluripotent Stem Cells, Organ-specific Adult Stem Cells), and Geography”, published by The Insight Partners, the global organoids market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027.

Get Exclusive Sample Pages of Organoids Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00017616/

Report Coverage

Details

Market Size Value in

US$ 689.47 Million in 2019

Market Size Value by

US$ 3,420.40 Million by 2027

Growth rate

CAGR of 22.1% from 2020-2027

Forecast Period

2020-2027

Base Year

2020

No. of Pages

174

No. Tables

84

No. of Charts & Figures

77

Historical data available

Yes

Segments covered

Type; Application; Source, and Geography

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Organoids Market: Competition Landscape and Key Developments

STEMCELL Technologies, Inc; Cellesce Ltd.; Hubrecht Organoid Technology; Definigen; 3Dnamics, Inc., Organoid Therapeutics; PeproTech, Inc.; Thermo Fisher Scientific; Corning Incorporated (Life Sciences); and Merck KGgA. are among the key companies operating in the global organoids market. Leading players are focusing on the expansion and diversification of their market presence and acquisition of new customer base, thereby tapping prevailing business opportunities.

Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPRE00017616/

In November 2020, Cellesce Ltd. entered into a partnership with Manchester BIOGEL to develop fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable manufacture, scale-up, and enhanced reproducibility of patient-derived organoids.

In October 2019, Corning Incorporated launched two new products—Elplasia and Matrigel—to its organoid culture portfolio to provide new solutions to support spheroid and organoid culture models. Elplasia, a 3D cell culture microplate, features a microcavity technology that enables high-volume spheroid formation, culture, and analysis. The Matrigel matrix for organoid culture is optimized to support organoid growth and differentiation.

In Sep-2018, STEMCELL Technologies Signed a partnership agreement with Brigham and Women’s Hospital to commercialize a human pluripotent stem cell-derived kidney organoid culture system.

In 2019, North America dominated the global organoids market. The market growth in the region is credited to rise in implementation of organoid-based research models in the biotechnology sector in the US and Canada. These novel technologies have helped the researchers to overcome limitations faced by 2D cell culture platforms as 3D spheroids offer a microenvironment that can mimic the properties of human tissue structures. The market growth in Canada and Mexico is attributed to the presence of international market players, increase in adoption of advanced technologies, and existence of supportive government regulations.

However, Asia Pacific is anticipated to account for the fastest growth in the organoids market. Increasing prevalence of chronic diseases and growing number of companies focusing on the countries in Asia Pacific for their geographical expansion and other strategies are likely to fuel the market growth.

Speak to Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00017616/

Based on type, the organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment accounted for more than 23% of the market share in 2019. In terms of application, the organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2019, owing to its consideration as a primary investigative research tool of the human developmental biology. In terms of source, the pluripotent stem cells segment accounted for a larger share in the organoids market in 2019.

Animal models are mainly used in biomedical research for human-specific diseases. However, several cases demonstrate that animal models cannot constantly predict human drug response, like drug toxicology studies. This is because there are broad variations in the metabolism of drugs and toxins in humans compared to animals, making it nearly impossible to study drug metabolism in experimental models such as laboratory rodent species. Additionally, in current years, numerous regulations have been achieved that restrict animal use in research projects. Similarly, several bodies, such as Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, oppose animal-based models for research purposes.

Therefore, to generate alternative testing models that can provide an environment with full equivalence to the human body, various institutes are developing alternative drug development and biomedical research methods. As organoids can serve as substitutes to animal models, the current focus on reducing animal use in research is anticipated to boost the growth of the human organoids market.

Organoids Market: Segmental Overview

In terms of type, the kidney segment is anticipated to register the highest CAGR in the organoids market during the forecast period. Kidney organoids, derived from human pluripotent stem cells, have the potential to assist the drug development process. An international team of researchers—led by Nanyang Technological University Singapore (NTU Singapore)—has grown “miniature kidneys” in laboratory, which could be used to better understand the mechanism of development of renal diseases in individual patients. The mini kidneys, i.e., kidney organoids, were grown in vitro from skin cells derived from a single patient who had polycystic kidney disease, one of the most common inherited causes of kidney failure in adults. In terms of application, the developmental biology disease segment accounted for more than 29% share in global organoids market in 2019. In terms of source, the market for the organ-specific adult stem segment is anticipated to grow at a steady pace during the forecast period.

Buy Premium Copy of Organoids Market Size, Share, Revenue, Strategic Insights and Forecasts 2020-2027 Research Report at https://www.theinsightpartners.com/buy/TIPRE00017616/

The COVID-19 pandemic outbreak in late 2019 has disturbed various trades and businesses across the world. The approach of the novel COVID-19 pandemic is expected to open new opportunities for the current organoid market landscape players. Human organoids allow testing treatments against COVID-19 in an agile way, dramatically reducing the time human drug trials take. Hurtado is part of an international research team that has identified a drug capable of blocking the effects of the SARS-CoV-2 virus. Further, ORGANOVIR (Organoids for Virus Research) contributes to COVID-19 research in various ways, and several of its researchers are currently working on developing new antivirals to combat the disease. Researchers at KU Leuven (Belgium) study how coronaviruses evolve and search out possible targets for further remedies. However, the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccines against COVID-19.

Browse Adjoining Reports:

Human Liver Models Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Other), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

Human Biobanking Equipment Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Type (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment); Application (Regenerative Medicine, Life Science Research, Clinical Research) and Geography

Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, and CTC Analysis), Application (Clinical/Liquid Biopsy and Research), and End User (Hospital and Clinics, Research and Academic Institutes, and Diagnostic Centers)

Latest Members

Recent AchievementsYou must be logged in to view earned achievements

What is a Wire Coin?

Find connections

Who is online

Latest Hashtags

#artificialintelligence #betting #blockchain #casino #esports #fintech #gaming #hiptherfestival #hipthers #igaming #slots #technology